🚀 VC round data is live in beta, check it out!
DocGo Valuation Multiples
Discover revenue and EBITDA valuation multiples for DocGo and similar public comparables like Biote, Radius Residential, Maternus-Kliniken, P3 Health Partners and more.
DocGo Overview
About DocGo
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
Founded
2020
HQ
Employees
4.4K
Website
Sectors
Financials (LTM)
EV
$29M
DocGo Financials
DocGo reported last 12-month revenue of $316M and negative EBITDA of ($23M).
In the same LTM period, DocGo generated $99M in gross profit, ($23M) in EBITDA losses, and had net loss of ($141M).
Revenue (LTM)
DocGo P&L
In the most recent fiscal year, DocGo reported revenue of $322M and EBITDA of ($29M).
DocGo expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $316M | XXX | $322M | XXX | XXX | XXX |
| Gross Profit | $99M | XXX | $99M | XXX | XXX | XXX |
| Gross Margin | 31% | XXX | 31% | XXX | XXX | XXX |
| EBITDA | ($23M) | XXX | ($29M) | XXX | XXX | XXX |
| EBITDA Margin | (7%) | XXX | (9%) | XXX | XXX | XXX |
| EBIT Margin | (44%) | XXX | (28%) | XXX | XXX | XXX |
| Net Profit | ($141M) | XXX | ($182M) | XXX | XXX | XXX |
| Net Margin | (45%) | XXX | (57%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
DocGo Stock Performance
DocGo has current market cap of $51M, and enterprise value of $29M.
Market Cap Evolution
DocGo's stock price is $0.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $29M | $51M | -9.9% | XXX | XXX | XXX | $-1.85 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDocGo Valuation Multiples
DocGo trades at 0.1x EV/Revenue multiple, and (1.3x) EV/EBITDA.
EV / Revenue (LTM)
DocGo Financial Valuation Multiples
As of April 11, 2026, DocGo has market cap of $51M and EV of $29M.
Equity research analysts estimate DocGo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
DocGo has a P/E ratio of (0.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $51M | XXX | $51M | XXX | XXX | XXX |
| EV (current) | $29M | XXX | $29M | XXX | XXX | XXX |
| EV/Revenue | 0.1x | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBITDA | (1.3x) | XXX | (1.0x) | XXX | XXX | XXX |
| EV/EBIT | (0.2x) | XXX | (0.3x) | XXX | XXX | XXX |
| EV/Gross Profit | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| P/E | (0.4x) | XXX | (0.3x) | XXX | XXX | XXX |
| EV/FCF | 2.1x | XXX | 1.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified DocGo Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
DocGo Margins & Growth Rates
DocGo's revenue in the last 12 month declined by (4%).
DocGo's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
DocGo's rule of 40 is (10%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
DocGo's rule of X is (21%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
DocGo Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (4%) | XXX | (7%) | XXX | XXX | XXX |
| EBITDA Margin | (7%) | XXX | (9%) | XXX | XXX | XXX |
| EBITDA Growth | (81%) | XXX | (71%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (10%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (21%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 0% | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 39% | XXX | 49% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 58% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
DocGo Public Comps
See public comps and valuation multiples for other Long-Term Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Biote | XXX | XXX | XXX | XXX | XXX | XXX |
| Radius Residential | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| P3 Health Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| Joint | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
DocGo M&A Activity
DocGo acquired XXX companies to date.
Last acquisition by DocGo was on XXXXXXXX, XXXXX. DocGo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by DocGo
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDocGo Investment Activity
DocGo invested in XXX companies to date.
DocGo made its latest investment on XXXXXXXX, XXXXX. DocGo invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by DocGo
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout DocGo
| When was DocGo founded? | DocGo was founded in 2020. |
| Where is DocGo headquartered? | DocGo is headquartered in United States. |
| How many employees does DocGo have? | As of today, DocGo has over 4K employees. |
| Who is the CEO of DocGo? | DocGo's CEO is Lee Bienstock. |
| Is DocGo publicly listed? | Yes, DocGo is a public company listed on Nasdaq. |
| What is the stock symbol of DocGo? | DocGo trades under DCGO ticker. |
| When did DocGo go public? | DocGo went public in 2021. |
| Who are competitors of DocGo? | DocGo main competitors are Biote, Radius Residential, Maternus-Kliniken, P3 Health Partners. |
| What is the current market cap of DocGo? | DocGo's current market cap is $51M. |
| What is the current revenue of DocGo? | DocGo's last 12 months revenue is $316M. |
| What is the current revenue growth of DocGo? | DocGo revenue growth (NTM/LTM) is (4%). |
| What is the current EV/Revenue multiple of DocGo? | Current revenue multiple of DocGo is 0.1x. |
| Is DocGo profitable? | No, DocGo is not profitable. |
| What is the current EBITDA of DocGo? | DocGo has negative EBITDA and is not profitable. |
| What is DocGo's EBITDA margin? | DocGo's last 12 months EBITDA margin is (7%). |
| What is the current EV/EBITDA multiple of DocGo? | Current EBITDA multiple of DocGo is (1.3x). |
| What is the current FCF of DocGo? | DocGo's last 12 months FCF is $14M. |
| What is DocGo's FCF margin? | DocGo's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of DocGo? | Current FCF multiple of DocGo is 2.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.